In this review, we summarize (1) the pathophysiology of inflammation in cardiovascular disease, (2) the function of HDACs in the regulation of atherosclerosis and cardiovascular diseases, and (3) the possible therapeutic implications of HDAC inhibitors in cardiovascular diseases, with perspective on the relationship between HDAC and inflammation. The gene discussed is HDAC9; the disease is atherosclerosis.